Albumin 25% IV is prescribed for a child with nephrotic syndrome. Which assessment finding indicates to the nurse that the medication is having the desired effect?

A. Improved caloric intake: While adequate nutrition is important for a child with nephrotic syndrome, albumin administration does not directly influence appetite or caloric intake. B. Reduction of edema: Albumin 25% increases plasma oncotic pressure, drawing fluid from the interstitial space into the vascular compartment. A decrease in edema demonstrates that the medication is effectively restoring fluid balance, which is the desired therapeutic effect. C. Reduction of fever: Albumin is not an antipyretic and does not treat fever. Fever reduction would not be an expected outcome of albumin therapy in nephrotic syndrome. D. Weight gain: Weight gain in nephrotic syndrome often reflects fluid retention, not improvement. The desired effect of albumin would typically result in stable or decreased weight as edema resolves.